Cessation of Sales. Each Selling Stockholder agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 5(a)(ii) hereof, such Selling Stockholder will forthwith discontinue disposition of Registrable Securities pursuant to the then current Prospectus until (1) such Selling Stockholder is advised in writing by the Company that a new Registration Statement covering the offer of Registrable Securities has become effective under the Securities Act or (2) such Selling Stockholder receives copies of any required supplemented or amended Prospectus, or until such Selling Stockholder is advised in writing by the Company that the use of the Prospectus may be resumed; provided, however, that the Company shall use its commercially reasonable efforts to cure any such misstatement, omission or event that is applicable to the Registration Statement as soon as reasonably practicable after delivery of such notice pursuant to clause (6) of Section 5(a)(ii) hereof. If so directed by the Company, on the happening of such event, each Selling Stockholder will deliver to the Company (at the Company's expense) all copies, other than permanent file copies then in such Stockholder's possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice.
Cessation of Sales. (a) Upon receipt of written notice from the Company pursuant to Section 5.1(e), each holder of Registrable Securities hereby agrees to discontinue the disposition of the Registrable Securities covered by a registration statement or prospectus until such order set forth in Section 5.1(e) has been withdrawn or lifted.
Cessation of Sales. Except for sales made in accordance with Section 16.12.2(a)(i) (Termination Other than for Cause by Akebia), Licensee will cease all sales of Licensed Product in the Territory.
Cessation of Sales. Each Beneficiary agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(a)(vi)(B) hereof, such Beneficiary will forthwith discontinue disposition of Registrable Shares pursuant to the then current prospectus until (i) such Beneficiary is advised in writing by the Company that a new registration statement covering the offer of Registrable Shares has become effective under the Securities Act, (ii) such Beneficiary receives copies of any required supplemented or amended prospectus, or (iii) such Beneficiary is advised in writing by the Company that the use of the prospectus may be resumed; provided, however, that the Company shall use its reasonable best efforts to cure any such misstatement, omission or event that is applicable to the registration statement as soon as reasonably practicable after delivery of such notice pursuant to Section 3(a)(vi)(B) hereof. Such periods of discontinued use of the registration statement shall not exceed 120 days in any 365-day period. If so directed by the Company, on the happening of such event, each Beneficiary will deliver to the Company (at the Company's expense) all copies, other than permanent file copies then in such Beneficiary's possession, of the prospectus covering such Registrable Shares current at the time of receipt of such notice.
Cessation of Sales. 4 4.3. Other Registrations.......................................4
Cessation of Sales. In the event of any registration of Registrable Shares under the Securities Act pursuant to this Agreement, Pfizer agrees that, upon receipt of any notice from ArQule of (i) any request by the SEC for amendments or supplements to a Registration Statement or related prospectus covering any of Pfizer’s Registrable Shares, (ii) the issuance by the SEC of any stop order suspending the effectiveness of a Registration Statement covering any of Pfizer’s Registrable Shares or the initiation of any proceedings for that purpose, (iii) the receipt by ArQule of any notification with respect to the suspension of the qualification of any Registrable Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, (iv) the happening of any event that requires amending or supplementing the Registration Statement, prospectus, prospectus supplement or post-effective amendment so that any of the foregoing will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, or (v) ArQule’s reasonable determination that a post-effective amendment to the Registration Statement or a supplement to any related prospectus is required under the Securities Act; Pfizer will immediately discontinue disposition of such Registrable Shares. Pfizer further agrees that (x) it shall not resume its disposition of Registrable Shares pursuant to such Registration Statement or related prospectus unless it has received notice from ArQule that such Registration Statement or amendment has become effective under the Securities Act and has received a copy or copies of the related prospectus (as then amended or supplemented, as the case may be), unless the Registrable Shares are then listed on a national securities exchange and ArQule has advised Pfizer that ArQule has delivered copies of the related prospectus, as then amended or supplemented, to such exchange and (y) if so directed by ArQule, such holder will deliver to ArQule (at ArQule’s expense) all copies, other than permanent file copies then in such stockholder’s possession, of the prospectus covering such Registrable Shares current at the time of receipt of such notice.
Cessation of Sales. Sales under this Sales Plan shall be suspended upon either (i) the date that the Issuer or any other person publicly announces a tender or exchange offer with respect to the Stock, (ii) the date of a public announcement of a merger, acquisition, reorganization, recapitalization or comparable transaction affecting the securities of the Issuer as a result of which the Stock is exchanged or converted into shares of another company, (iii) the date on which Issuer receives notice of the commencement of any proceedings in respect of or triggered by Seller's bankruptcy or insolvency, or (iv) the date that an officer in Issuer's legal department notifies either Seller or Broker that sales under the Sales Plan are suspended pursuant to the Issuer's insider trading policy or any other Issuer policy in Issuer's solx xxxxxxxxxx. Xo further sales shall be made under this Sales Plan after its suspension until Issuer notifies Broker and Seller that trading may resume under the Sales Plan.
Cessation of Sales. From and after the Closing Date, Sellers will cease selling and shipping all Products and shall turn over to Purchaser any open and unfilled orders for such Products, as part of the Assets purchased by Purchaser.
Cessation of Sales. Each Shareholder agrees that, upon receipt of any notice from the Company of the happening of a Material Event, such Shareholder will forthwith discontinue disposition of Registrable Securities pursuant to the then current prospectus until (i) such Shareholder is advised in writing by the Company that a new registration statement covering the offer of Registrable Securities has become effective under the Securities Act, (ii) such Shareholder receives copies of any required supplemented or amended prospectus, or (iii) such Shareholder is advised in writing by the Company that the use of the prospectus may be resumed; provided, however, that the Company shall use its reasonable best efforts to cure any such misstatement, omission or event that is applicable to the registration statement as soon as reasonably practicable after delivery of such notice of the happening of a Material Event. Such periods of discontinued use of the registration statement shall not exceed 120 days in any 365-day period. If so directed by the Company, on the happening of a Material Event, each Shareholder will deliver to the Company (at the Company's expense) all copies, other than permanent file copies then in such Shareholder’s possession, of the prospectus covering such Registrable Securities current at the time of receipt of such notice.
